A woman is joining thousands of others in filing a Ventralex hernia mesh lawsuit over severe adverse side effects she suffered following a hernia mesh implantation.

Plaintiff Jolene G. is filing the Ventralex hernia mesh lawsuit demanding a trial by jury.

According to the Ventralex hernia mesh lawsuit, Jolene, a resident and citizen of Alaska, says that it was in September 2015 when she underwent repair of an epigastric incisional hernia at Fairbanks Memorial Hospital in Fairbanks, Alaska.

However, due to severe complications and adverse side effects, she says, she later underwent surgery to explant the hernia mesh on Aug. 11, 2016. According to the lawsuit, during the surgery the hernia mesh was found to be folded over in her body.

The Ventralex hernia mesh lawsuit was filed on multiple counts including manufacturing defect, design defect, failure to warn, negligence, breach of implied warranty, negligent infliction of emotional distress, fraudulent concealment, negligent misrepresentation and punitive damages.

Overview: Ventralex Hernia Mesh Lawsuit

Thousands of lawsuits have been filed over adverse side effects and complications stemming from implantation of the Ventralex hernia mesh.

Side effects have included adhesions, autoimmune reactions to mesh, nerve damage, bowl or intestinal blockage, pain and bleeding and seroma or fluid buildup at the surgery site.

The side effects arise from the hernia mesh’s unique coating that uses fish oil. The Ventralex is a hernia mesh patch made from polypropylene.

Although the product’s manufacturers, Bard and its subsidiary Davol Inc., claim that the product’s coating helps reduce tissue attachment to the hernia mesh and helps stop the hernia mesh from touching other internal organs in the body, there have been a serious number of adverse side effects and complications.

Adverse side effects have included:

• Infection
• Mesh migration
• Mesh shrinkage
• Organ damage
• Nerve damage
• Recurring hernia
• Bleeding
• Pain
• Swelling and redness
• Internal scar tissue
• Mesh distortion
• Required revision surgery
• Seromas (fluid build-up)

Bard’s Ventralex was originally approved by the U.S. Food and Drug Administration (FDA) on July 16, 2002. It was approved through the FDA’s 510 (k) approval program that allowed Bard to skip research and pre-market approval studies.

To go through the approval system, Bard contended that the Ventralex was substantially equivalent to another hernia mesh product already on the market, the Kugel mesh. However, the Kugel mesh was recalled in March 2006 for the severe complications its caused. Only a limited number of Ventralex hernia mesh devices have been recalled to date.

Despite the known side effects and complications of the Ventralex polypropylene mesh and the fact that Bard is facing thousands of lawsuits in federal courts, the mesh is still being implanted in victims across the nation.

No recall has been announced by the FDA and nor has there been a Ventralex mesh class action lawsuit filed against the company.

If you or a loved one have suffered from adverse side effects and complications stemming from a Ventralex hernia mesh implantation, you may be eligible to file a Ventralex hernia mesh lawsuit to obtain recoveries for your damages.

The Ventralex Hernia Mesh Lawsuit is Case No. 3:18-cv-00184-HRH, in the U.S. District Court for the District of Alaska.